Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.66 | N/A |
PEG Ratio (TTM) | -0.15 | N/A |
P/S Ratio (TTM) | 0.27 | N/A |
P/B Ratio (TTM) | 0.67 | N/A |
P/FCF Ratio (TTM) | -8.24 | N/A |
Price to 5YR AVG Earnings Ratio | -39.69 | N/A |
Price to 5YR AVG FCF Ratio | 21.86 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.15% | N/A |
ROE (TTM) | -22.79% | N/A |
Net Profit Margin (TTM) | -10.26% | N/A |
ROIC 5YR AVG | -389.89% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 841.49% | -141.31% | -24.15% |
Revenue | 6.18% | -14.36% | -29.34% |
Net Income | 836.05% | -142.24% | -23.69% |
Cash Flow | -393.62% | -63.58% | 32.94% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.27 | N/A |
Quick Ratio (TTM) | 0.56 | N/A |
D/E Ratio (TTM) | 3.04 | N/A |
Interest Coverage (TTM) | -1.98 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 7.56 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | 1.20% | N/A |